Authors


K Meyer-Böhm

Latest:

Development of Orally Disintegrating Tablets Based on a New Excipient

The authors examine the effectiveness of an excipient comprised of mannitol, polyvinyl acetate, and crospovidone using model actives loperamide hydrogen chloride and caffeine.


Raafat Bishai

Latest:

Extrapolating Data from Adult Clinical Trials to Advance Pediatric Drug Development

Extrapolating data from adult clinical trials to a pediatric population is a proven method to avoid unnecessary pediatric clinical trials. Representatives of the Pediatric Working Group of the IQ Consortium share case studies that demonstrate how adult clinical trial data can be used to support the dose selection and regimen—or waive the need for a placebo control arm—for pediatric studies.



Wolfgang Schmitt

Latest:

Detecting GMP failures

An effective quality management system will identify the root cause of non-conformances and put measures in place to ensure that they do not recur, but is the pharmaceutical industry choosing the right methods to make sure this happens?


Angela James

Latest:

Extrapolating Data from Adult Clinical Trials to Advance Pediatric Drug Development

Extrapolating data from adult clinical trials to a pediatric population is a proven method to avoid unnecessary pediatric clinical trials. Representatives of the Pediatric Working Group of the IQ Consortium share case studies that demonstrate how adult clinical trial data can be used to support the dose selection and regimen—or waive the need for a placebo control arm—for pediatric studies.


Actylis

Latest:

Importance of a Hybrid Approach to Manufacturing and Sourcing

Bradley Grobler, Vice President of Sales, Pharma & Biopharma Europe, describes how Actylis meets global demands for (bio)pharmaceutical development and manufacturing programs during CPhI 2023.


IPS-Integrated Project Services, LLC

Latest:

IPS Tech Talks

Whether you are considering a new facility build or a facility upgrade, IPS has expert teams using the latest technologies to bring you strategies that provide cost certainty, real-time updates, and successful construction project management.


Carl L. McMillian

Latest:

Viewpoint: Precompetitive Collaboration Drives Pharma Industry Innovation

The IQ Consortium marks a decade of impactful innovation of collaboration through a network of pharmaceutical companies driving change for the bio/pharmaceutical industry.


Jacqueline Wolfrum

Latest:

The Impact of SARS-CoV-2 on Biomanufacturing Operations

This article presents the results of a survey conducted to gain insight on the impact of the COVID-19 pandemic on biomanufacturing operations.


Metrics Contract Services

Latest:

Formulation and Evaluation of Enteric Coated Aspirin Capsules

In this study, the ability of the enteric coating to properly seal and protect capsule contents through various analytical tests was analyzed using dissolution vessels containing acidic media.


Marc Wolman

Latest:

Viral Vector API Characterization of Product-Related Impurities

FDA’s final CMC guidance sets expectations for manufacturing and quality for human gene therapy INDs. This article reviews existing analytical applications, focusing on viral vector characterization of impurities.


Andrew Badrot

Latest:

Optimizing the Total Cost of Ownership for APIs

All members of the pharmaceutical supply chain must implement reliable sourcing and manufacturing strategies that balance quality and costs to ensure the uninterrupted supply of high-quality medicines to patients worldwide.


Parsec Automation

Latest:

Discover The Business Value of TrakSYS™

Through in-depth interviews with leading global manufacturers, the International Data Center (IDC) established the impact TrakSYS has on manufacturing operations.


Rostam Namdari

Latest:

Using Modified QbD to Develop a Novel Pediatric Formulation of Ezogabine

The epilepsy treatment, Potiga, has been used off-label to treat specific types of epilepsy in some children. However, it has never been formally evaluated in pediatric clinical trials. Using a modified QbD approach, the authors have developed a granular formulation suitable for use in clinical trials involving infants and children.


Eric Unrau

Latest:

Accelerating Project Delivery with a Lean Alternative to DBB

Lean delivery offers a promising solution to supply and manufacturing bottlenecks by integrating project teams early on and widening the team’s field of view.



Jonathan Dakin

Latest:

Supply Chain Challenges Creating Hurdles to COVID-19 Vaccine Production

The availability of materials is a critical factor when it comes to vaccine capacity.


Yanhuai (Richard) Ding

Latest:

Considerations for Monoclonal Antibody Bioprocess and Manufacturing Validation

Regulatory, analytical, and process concerns must be taken into account.



Zachary Digby

Latest:

Determining Low PPB Levels of Nitrite in Polymeric Excipients

In this paper, the authors introduce a method that combines ion exchange chromatography with an easier-to-perform, simpler one-step post-column derivatization that is selective to nitrite and visible spectrophotometric detection to allow high sample loading volumes without affecting resolution.


Adare Pharma Solutions

Latest:

A Big Impact: Trends Shaping Small-Molecule APIs, Excipients, and Formulations

Webinar Date/Time: Thursday, September 21, 2023 at 11am ET | 10am CT | 8am PT | 4 pm BST


Chuck Lambert

Latest:

Nitrosamides–Should They Be Treated the Same as Nitrosamines?

The authors discuss the differences in mechanism of activation of N-nitrosamides versus N-nitrosamines and the fact that they should not be treated the same.


Jun Lu

Latest:

Viral Vector API Characterization of Product-Related Impurities

FDA’s final CMC guidance sets expectations for manufacturing and quality for human gene therapy INDs. This article reviews existing analytical applications, focusing on viral vector characterization of impurities.


Chris Smalley

Latest:

Understanding Pharmaceutical Compounding from Multiple Perspectives

Meeting patient needs and achieving high quality are common goals for all stakeholders.


Dennis Powers

Latest:

The Quest for Cleanroom Flexibility

Contextualizing what type of flexibility is needed is paramount when considering cleanroom design.


Judy Shimek-Cox

Latest:

The Ideal Pharmacopeia

This position paper describes a model for the future that would provide appropriate standardization, facilitate drug registration and support regulatory agencies.


Matteo De Nigris

Latest:

Enhancing Process Validation for Sterile Liquid and Freeze-Dried Forms: Part 1

AFI representatives of the process validation working group explore and define key elements for an enhanced approach to process validation for sterile liquid and freeze-dried forms.



Joseph Zeleznik

Latest:

Understanding Excipient Characteristics to Ensure Robust Continuous Manufacturing

Key information is needed for excipients and their potential impact on continuous manufacturing processes.


Scott Weiss

Latest:

Integrated Approaches to the Data Lifecycle

An integrated approach to the data lifecycle is key to successful digital transformation.